Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Wednesday preview: Compass and Burberry results

(Sharecast News) - Economic data is set to take a back seat on Wednesday, and while the corporate earnings calendar in London is relatively quiet, results from Compass and Burberry will be in focus. Contract caterer Compass will report its results for the half year ended 31 March, with investors keen to see if the impressive 9.2% underlying sales growth reported for the first quarter continued into the second.

Despite the strong start, the company in February held on to guidance organic growth of 7.5% for the full year and underlying operating profit growth in the high single digits.

"With consensus forecasts already wandering into double-digit growth territory, there may be some disappointment if Compass doesn't serve up an upgrade alongside [the] half-year results," said Derren Nathan, head of equity analysis at Hargreaves Lansdown.

As for Burberry, the high-end luxury brand's results for the financial year ended 30 March will likely focus on the outlook statement - particularly around the potential impact that Donald Trump's trade tariffs will have on the bottom line, given the company's heavy exposure to the Chinese market.

"The financial year for the fashion house ended before President Trump unleashed his Liberation Day plan onto the world, and the China/US trade war ramped up," noted Susannah Streeter, head of money and markets at Hargreaves Lansdown.

"Given that China has been the powerhouse for luxury brands, another knock to confidence in the vast country is likely to hurt Burberry, which had shown signs of turning around its sales performance in the Asia Pacific region."

Streeter also warned of the impact that the knock-on effects of the tariffs would have on prices for consumers in the US. "The American market [...] had been a brighter spot for Burberry, with like-for-like revenue rising 4% at the last count, so a knock in confidence will be a set-back," Streeter said.

A host of corporate earnings are also due from blue chips across Europe, including ABN Amro, Alstom, Daimler Truck, E.ON, Hapag-Lloyd, Telefonica and TUI Group.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.